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GABAergic interneurons are crucial to controlling the excitability
and responsiveness of cortical circuitry. Their developmental origin
may differ between rodents and human. We have demonstrated the
expression of 12 GABAergic interneuron-associated genes in
samples from human neocortex by quantitative rtPCR from 8 to 12
postconceptional weeks (PCW) and shown a significant anterior to
posterior expression gradient, confirmed by in situ hybridization or
immunohistochemistry for GAD1 and 2, DLX1, 2, and 5, ASCL1,
OLIG2, and CALB2. Following cortical plate (CP) formation from 8 to
9 PCW, a proportion of cells were strongly stained for all these
markers in the CP and presubplate. ASCL1 and DLX2 maintained high
expression in the proliferative zones and showed extensive immuno-
fluorescent double-labeling with the cell division marker Ki-67.
CALB2-positive cells increased steadily in the SVZ/VZ from 10 PCW
but were not double-labeled with Ki-67. Expression of GABAergic
genes was generally higher in the dorsal pallium than in the gangli-
onic eminences, with lower expression in the intervening ventral
pallium. It is widely accepted that the cortical proliferative zones
may generate CALB2-positive interneurons from mid-gestation; we
now show that the anterior neocortical proliferative layers especially
may be a rich source of interneurons in the early neocortex.
Keywords: cerebral cortex, DLX genes, GABA, GABRB3, inhibitory
interneurons, neurodevelopmental disorders
Introduction
The developmental origin of GABAergic interneurons in the
neocortex in primates is controversial. While it is established
that, in mice, these interneurons are born almost entirely
outside the neocortex (dorsal pallium) in the ganglionic emi-
nences (GE) and associated structures such as the septum and
preoptic area (subpallium) from which they migrate tangen-
tially into the cortex (De Carlos et al. 1996; Parnavelas 2000;
Marín and Rubenstein 2003; Welagen and Anderson 2011) in
human, there is evidence for significant intracortical pro-
duction. Immunohistochemistry (IHC) and retroviral labeling
of slice preparations showed that between 10 and 25 postcon-
ceptional weeks (PCW) the majority of GABAergic inter-
neurons are generated within the cortical progenitor zones
(Letinic et al. 2002). This interpretation was supported by
double-labeled immunohistochemical studies (Zecevic et al.
2005; Mo and Zecevic 2008) and in the analysis of malfor-
mations that involve deletion of the GE (Fertuzinhos et al.
2009). Furthermore, interneurons can be generated in vitro
from human, but not rodent, cortical radial glial progenitor
cells (Yu and Zecevic 2011). Studies in the macaque have
widened these observations to other primates (Petanjek et al.
2009). However, a study of birth-dated neurons in 15 PCW
human cortical cultures did not reveal GABA immunoreactive
postmitotic cells in the subventricular zone (SVZ) of the corti-
cal wall despite the identification of progenitor cells expressing
the early interneuron marker ASCL1 (Hansen et al. 2010)
whereas cells double-labeled for the cell division marker Ki67
and CALB2 (calretinin) were detected histologically in the 20
PCW fetus (Zecevic et al. 2011). This discrepancy may point
to differences in timing and location of expression of
GABA-related genes during early human fetal cortical develop-
ment (Molnár and Clowry 2012).
In the rodent, parvalbumin- and somatostatin-positive
GABAergic neurons arise from ventral and dorsal parts of the
medial ganglionic eminence (MGE), respectively, initially en-
tering the neocortex by tangential migration into the frontal
two thirds of the neocortex, whereas Calb2-positive inter-
neurons arise from the caudal ganglionic eminence (CGE)
initially entering more caudal regions before populating the
whole neocortex (Xu et al. 2004; Butt et al. 2005; Wonders and
Anderson 2005; Ghanem et al. 2007; Faux et al. 2012). In the
human neocortex, the numbers of CALB2-positive neurons in-
creases from about 12 PCW, particularly, in the SVZ (Meyer
et al. 2002; Bayatti, Moss et al. 2008; Zecevic et al. 2011) and in-
terestingly, at this stage of development, the rostral neocortex
is far more densely populated with CALB2 neurons than the
caudal pole, suggesting that they were unlikely to arise by
migration from the CGE (Bayatti, Moss et al. 2008; Zecevic
et al. 2011). CALB2 interneurons are more prevalent in the
adult primate than in the rodent (Conde et al. 1994; Gabbott
et al. 1997; Wonders and Anderson 2005). There are other
interneuron subtypes, such as the calbindin-positive double
bouquet cell, which are numerous in primate, but missing or
greatly reduced in other species (Ballesteros Yáñez et al.
2005). GABAergic interneurons play a crucial role in cognitive
processing, fine-tuning the oscillations in neural activity in dis-
tributed networks that underlie learning and memory (Wang,
Dye et al. 2010; Whittington et al. 2011). Failures in prolifer-
ation and migration of specific classes of GABAergic inter-
neurons have been implicated in diverse conditions including
autism, epilepsy, and schizophrenia (De Felipe 1999; Lewis
et al. 2005; Uhlhaas and Singer 2010; Marín 2012). We must
question whether mouse models are appropriate for the study
of these diseases (Jones 2009; Clowry et al. 2010).
We have previously carried out a microarray study of differ-
ential gene expression between the anterior and posterior
poles of the human neocortex at 8–12 PCW (Ip et al. 2010).
One striking finding was that a large number of genes associ-
ated with GABAergic neurotransmission appeared to be more
highly expressed anteriorly than posteriorly (see Table 1). In
the present study, we have set out to better determine the rela-
tive levels of expression of a subset of these genes by carrying
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out quantitative real-time polymerase chain reaction (qPCR) on
RNA samples collected between 8 and 12 PCW from anterior
and posterior neocortex. We have compared these results with
those obtained by microarray (Ip et al. 2010) and whole RNA
sequencing (http://brainspan.org/rnaseq/search/index.html
[date last accessed; 6 September 2013]). Then we studied
expression in human tissue sections using in situ hybridization
(ISH) and IHC to determine the location and type of cell expres-
sing these genes, as well as confirming expression gradients.
The subset chosen for investigation include a number of tran-
scription factors. Ascl1 (achaete-scute complex like homolog 1,
also known asMash1) is expressed in ventral telencephalon and
specific areas of the diencephalon in rodents where it promotes
differentiation of GABAergic interneurons (Casarosa et al. 1999;
Horton et al. 1999; Yun et al. 2002). Letinic et al. (2002) inter-
preted evidence that ASCL1 expression in progenitor cells and
postmitotic GABAergic neurons of the dorsal pallium, in orga-
notypic cultured explants of human forebrain from 13 weeks
gestation, indicated that GABAergic neurons are born there
rather than having migrated there. GABAergic interneurons
were observed to migrate from subpallium to pallium in these
explants but had ceased to express ASCL1 on leaving the ventral
proliferative zones. Ascl1 acts together with Dlx 1 and 2 (distal-
less homeobox) in coordinating the differentiation of precursors
of GABAergic interneurons by regulating Notch signaling, Ascl1
being expressed earlier in development and Dlx1/2 later (Yun
et al. 2002). Dlx5 and 6 are expressed in both developing and
mature inhibitory interneurons, and may be necessary for the
migration and differentiation, but not production, of interneurons
born in the GE. Furthermore, they appear to be particularly
important in specifying differentiation of parvalbumin-expressing
basket cells (Wang, Dye et al. 2010).
In rodents, Lhx6 is a transcription factor expressed in the
MGE and is required for the specification of parvalbumin- and
somatostatin-positive interneurons in the neocortex and the
hippocampus. It is required for the normal tangential and
radial migration of GABAergic interneurons in the cortex
(Liodis et al. 2007). However, LHX6 expression has been
detected in the human cortical proliferative zones at 8 PCW
(Jakovcevski et al. 2011). Similarly, Olig2 is a marker for the
proliferative zones of subpallial structures in developing
rodent forebrain, showing an inverse pattern of expression
with Pax6, the cortical progenitor marker (Heins et al. 2002).
Olig2 expressing progenitors can give rise to neurons early in
development, including GABAergic neurons in the GE and oli-
godendrocytes at later stages (Takebayashi et al. 2000; Miyoshi
et al. 2007). However, it is already known that, in human,
the distinction is less clear cut, with numerous cells in cortical
VZ/SVZ and in the GE at mid-gestation co-expressing both
PAX6 and OLIG2 (Mo and Zecevic 2008).
We also studied the isoforms of the GABA synthesizing
enzyme, glutamate decarboxylase (GAD) 67 and 65 kiloDaltons,
coded for by the genes GAD1 and GAD2 (Erlander et al. 1991)
and CALB2 (calretinin), a calcium binding protein expressed
early in development by a subset of GABAergic neurons
(Fonseca et al. 1995; Ulfig 2002) as well as genes coding for 3
subunits of the GABA-A ionotropic receptor, GABRA5,
GABRB1, and GABRB3 (Olsen and Sieghart 2008) all potentially
more highly expressed anteriorly than posteriorly (see Table 1).
The establishment of cortical neurogenesis of GABAergic inter-
neurons in human at these stages of development, including
localization of this phenomenon to more anterior regions of the
cortical wall, adds greatly to our understanding of the difference
between primate and rodent cortical development.
Materials and Methods
Human Embryonic and Fetal Brains
Human embryonic and fetal tissue was obtained from the joint MRC/
Wellcome Trust-funded Human Developmental Biology Resource
(HDBR, http://www.hdbr.org [date last accessed; 6 September 2013])
with appropriate maternal written consent and approval from the New-
castle and North Tyneside NHS Health Authority Joint Ethics Commit-
tee. HDBR is regulated by the UK Human Tissue Authority (HTA; www
.hta.gov.uk) and operates in accordance with the relevant HTA Codes
of Practice. Fetal staging was estimated from modified Carnegie
Staging criteria (6.5–8 PCW, Bullen and Wilson 1997) or foot and
crown-rump lengths (9–15 PCW) (Hern 1984). Fetal samples from ages
6.5–15 PCW were used for IHC and ISH (n = 43), and ages 8–12 PCW
were used for qPCR (n = 8). Prior to sectioning, brains were fixed for at
least 24 h at 4 °C in 0.1 M phosphate-buffered saline (PBS) containing
4% paraformaldehyde (PFA; Sigma Aldrich, Poole, UK). Whole or half
brains (divided sagittally) were transferred to 70% ethanol for storage
at 4 °C prior to paraffin embedding. Thick sections (8 µm) were usually
cut sagittally, but sometimes coronally or horizontally, mounted on
slides, and used for tissue ISH and IHC. For the immunofluorescence
study, the frontal cortex from an 11 PCW fetus was fixed, cryoprotected
in 30% sucrose in PBS, and sectioned with a cryostat; 20 µm sections
were collected directly onto slides.
RNA Isolation and Reverse Transcription
As previously described (Ip et al. 2010), right-sided cortices were dis-
sected; subcortical structures, temporal lobes, and meninges removed;
and 5 mm slices cut along the anterior–posterior axis. Total RNA was
isolated from the anterior-most and posterior-most slices using the
PeqGOLD RNAPure reagent (Peqlab, Fareham, UK) according to the
manufacturer’s instructions. The cDNA templates were synthesized by
reverse transcription first-strand synthesis reaction from the extracted
RNA using random hexadeoxynucleotide primers (Promega, South-
ampton, UK) and SuperscriptTM III Reverse Transcriptase Kit (Invitro-
gen, Paisley, UK) following the manufacturer’s instructions for 2 μg of
total RNA in a final volume of 50 μL. The transcribed cDNA template
was further diluted 2-fold prior to the application of qPCR.
Table 1
Regionalized expression of GABAergic genes in the human neocortex 8–12.5 PCW from U133 plus
2.0 Array Affymetrix gene chip study (Ip et al. 2010)
Fold difference
A> P
Gene
name
Description (from rodent studies)
7.81 DLX5 GABA interneuron progenitor: transcription factor
7.40 DLX1 GABA interneuron progenitor: transcription factor
6.57 DLX2 GABA interneuron progenitor transcription factor
6.49 ISL1 LGE-derived progenitor transcription factor
5.53 OLIG1 GABA interneuron/oligodendrocyte progenitor marker
3.71 DLX6 GABA interneuron phenotype induction transcription factor
4.77 OLIG2 GABA interneuron/oligodendrocyte progenitor marker
3.42 GAD1 GABA synthesizing enzyme (GAD 67)
3.15 NKX2.1 Subpallial GABA interneuron progenitor transcription factor
2.47 LHX6 MGE-derived GABA interneuron progenitor transcription
factor
2.32 NPYR5 NPY receptor, GABA interneuron marker
2.28 ER81 Dorsal LGE interneuron progenitor transcription factor
2.09 GABRB3 GABA A receptor β subunit
1.99 VIAAT Inhibitory amino acid transporter (Glycine/GABA)
1.88 ASCL1 GABA interneuron progenitor transcription factor
1.85 NKX2.2 Subpallial GABA interneuron progenitor transcription factor
1.85 CALB1 GABA interneuron postmitotic phenotypic marker calbindin
1.82 GABRA5 GABA A receptor α subunit
1.75 GAD2 GABA synthesizing enzyme (GAD 65)
1.75 GABRB1 GABA A receptor β subunit
1.63 CALB2 GABA interneuron postmitotic phenotypic marker calretinin
A > P, anterior expression greater than posterior expression.
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Quantitative Real-Time PCR
The expression levels of 12 GABAergic interneuron-related genes
(ASCL1, CALB2, DLX1, DLX2, DLX5, GABRA5, GABRB1, GABRB3,
GAD1, GAD2, LHX6, and OLIG2) and 3 reference (housekeeping)
genes (β-ACTIN, GAPDH, and SDHA) (Vandesompele et al. 2002) in
the anterior-most and posterior-slices of neocortex (see above) were
measured by qPCR. Primers were designed according to the standard
criteria for PCR primer design using the Primer3 (v. 0.4.0) designing
program (http://frodo.wi.mit.edu/primer3/ [date last accessed; 6
September 2013]). Primers synthesis and product sequencing for
quality control were performed by Eurofins MWG Operon© (http://
www.eurofinsgenomics.eu [date last accessed; 6 September 2013]).
Table 2 shows the sequence and product size of each primer used.
A SYBR Green-based rtPCR assay was performed in 7900HT Fast
Real-Time PCR system (Applied Biosystems, Warrington, UK). A total
volume of 10 μL qPCR reaction was set up in triplicates, containing
5 μL of 2 × SYBR Green qPCR Master Mix (Invitrogen, Paisley, UK),
1 μL of the diluted cDNA template, 0.5 μL of each primer (10 ρmol/μL),
and 3 μL of Molecular Biology grade water. A negative control was
incorporated by replacing the cDNA template with Molecular Biology
grade water (VWR International, Lutterworth, UK). A standard thermal
cycle protocol was used as previously described (Ip et al. 2010). The
results of each reaction were analyzed by uploading raw data to
the Real-Time PCR Miner web site (http://www.miner.ewindup.info
[date last accessed; 6 September 2013]). This calculated the reaction
efficiency and the fractional cycle number at threshold (CT) for each
reaction (Zhao and Fernald 2005).
Quantitative Analysis of RNA Expression by Gene Chip,
RNAseq, and qPCR
In order to verify our previous observations obtained by microarray (Ip
et al. 2010), we compared these data with previously published
RNAseq data (http://brainspan.org/rnaseq/search/index.html) and
with qPCR data collected in the present study which was all converted
to expression relative to the geometric mean expression of 3 reference
genes (see above). A paired Student’s t-test was used to determine the
significance of differences between anterior and posterior expression.
To make the 3 studies comparable, we calculated expression levels for
all genes of interest relative to expression of the same reference genes.
Microarray data were obtained using the Human Genome U133 Plus
2.0 Array (Affymetrix Ltd., High Wycombe, UK) as previously de-
scribed (Ip et al. 2010). GeneSpring GX7.3 software (Agilent Technol-
ogies, South Queensferry, UK) was used to undertake expression
analysis. Expression for each probe was normalized by GC-RMA, and
using the most highly expressed probe set for each gene of interest, the
relative expression of each gene was calculated by dividing its
expression level by the average expression of the 3 reference genes for
each sample. Mean relative expression over the 6 samples, between 8
and 12.5 PCW of age, was calculated along with 95% confidence limits.
A paired Student’s t-test was used determine the significance of differ-
ences between anterior and posterior expression.
RNA seq data, obtained from RNA collected as part of the study of
(Kang et al. 2011) was accessed via the database at http://brainspan.
org/rnaseq/search/index.html. Anterior pole data were derived from 7
samples from 4 fetuses, the dorsolateral and ventrolateral prefrontal
cortex at 8, 9, and 12 PCW (2 fetuses at 12 PCW, no data available for
the dorsolateral prefrontal cortex at 9 PCW). Posterior pole data were
taken from 4 samples from the same 4 fetuses labeled occipital cortex
at 8 and 9 PCW and primary visual cortex at 12 PCW. The relative
expression of each gene was calculated by dividing its expression level
by the average expression of the 3 reference genes for each sample.
Mean relative expression of the 7 anterior samples and 4 posterior
samples, between 8 and 12 PCWof age, was calculated along with 95%
confidence limits. An unpaired Student’s t-test was used determine the
significance of differences between anterior and posterior samples.
Manufacture of TISH Probes
Total RNAs from human fetal whole brain or neocortex aged between
8 and 12 PCW were isolated with Trizol (Invitrogen) according to the
manufacturer’s instructions and reverse transcribed into cDNA tem-
plates. Gene-specific primer sets (Eurofins MWG Operon) were de-
signed using Primer 3 program (http://frodo.wi.mit.edu/primer3/) and
were incorporated with either SP6 (forward) or T7 (reverse) consensus
sequences. The primer sequences and amplicon size for each probe
are listed in Table 3. Procedures and conditions for PCR, and sub-
sequent gel extraction, in vitro transcription Digoxigenin (DIG)-
labeling reaction, labeled probes purification, and quality controls
were carried out as previously described (Bayatti, Sarma et al. 2008).
Tissue in Situ Hybridization
ISH was performed as previously described (Bayatti, Sarma et al. 2008)
with some modifications. Paraffin sections were de-waxed and rehy-
drated before being incubated with proteinase K (20 μg/mL; Sigma-
Aldrich) for 8 min at room temperature. Sections were fixed in 4% PFA/
PBS for 20 min, washed in PBS, and treated with 0.1 M triethanolamine
(Sigma-Aldrich, pH 8.0)/0.25% acetic anhydride (Sigma-Aldrich)/0.2%
HCl for 10 min, dehydrated in ethanol and air-dried. DIG-labeled probes
(300 ng) were used per 100 μL of DIG Easy Hyb mixture (Roche, Lewes,
UK). Probe/Hybmix (200 μL) was used per slide, covered with glass cov-
erslips. Slides were incubated in a hybridization chamber overnight at
68 °C, rinsed in 5× standard sodium citrate (SSC, pH 7.2) at 65 °C to
remove coverslips, followed by 3 washes at 50 °C (2 × SSC twice and
0.2 × SSC once), followed by 1 wash with 0.2 × SSC once at room temp-
erature. After briefly rinsing in 0.1 M Tris (pH 7.6)/0.15 M NaCl (Buffer
1) and blocking with 10% fetal calf serum (Invitrogen)/Buffer 1 for 1 h at
room temperature, sections were incubated with anti-DIG antibody
(Roche; diluted 1:1000 in 2% FCS/Buffer 1) overnight at 4 °C. Sections
were washed in Buffer 1 for 6 × 30 min. Detection of probes/anti-DIG
antibody was achieved by addition of NBT/BCIP solution (Roche; 20 μL/
mL) in 0.1 M Tris (pH 9.5)/0.1 M NaCl (Buffer 2). The color reaction was
developed in the dark for several hours to overnight and terminated by
rinsing slides in Buffer 2 and then distilled water. Sections were
mounted in Aquamount. Comparison of staining between sense and
antisense probes was carried out to ensure specificity (see Supplemen-
tary Fig. 1).
Immunohistochemistry and Immunofluorescence
Paraffin sections of forebrain were immunoperoxidase stained on
slides, according to standard protocols as previously described
(Bayatti, Moss et al. 2008). Details of the sources of primary antibodies
used and working dilutions are provided in Table 4. Biotinylated sec-
ondary antibodies and streptavidin-HRP conjugates were obtained
from Vector Labs (Peterborough, UK). Ready-made diaminobenzidine
solution was obtained from Invitrogen.
Frozen-fixed sections were immunofluorescently stained on slide.
Sections were incubated with a mixture of 2 primary antibodies at the
appropriate concentration (see Table 4) and the appropriate serum
Table 2
Primers sets used in rtPCR experiment
Primers Forward primera Reverse primera Product size (bp)
ASCL1 TGCACTCCAATCATTCACG GTGCGTGTTAGAGGTGATGG 146
Β-ACTINb CTACAATGAGCTGCGTGTGGC CAGGTCCAGACGCAGGATGGC 271
CALB2 GCTCCAGGAATACACCCAAA CAGCTCATGCTCGTCAATGT 208
DLX1 TGTCTCCTTCTCCCATGTCC ACTGATGTAGGGGCTGGATG 167
DLX2 GCACATGGGTTCCTACCAGT TCCTTCTCAGGCTCGTTGTT 153
DLX5 ACCAACCAGCCAGAGAAAGA GCAAGGCGAGGTACTGAGTC 151
GAPDHb TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 86
FGFR3 CCACTGTCTGGGTCAAGGAT TGTGTCCACACCTGTGTCCT 233
GABRA5 ATCTTGGATGGGCTCTTGG TGTACTCCATTTCCGTGTCG 130
GABRB1 GTTTGTGTTCCTGGCTCTGC GGCACTCTGGTCTTGTTTGC 100
GABRB3 CAGCATCGACATGGTTTCC TCGATTGTCAAGCGTGAGG 124
GAD1 AGGCAATCCTCCAAGAACC TGAAAGTCCAGCACCTTGG 218
GAD2 CGCATGGTCATCTCAAACC AGTGGAACAGCTTGGTGAGC 114
LHX6 ACAGATCTACGCCAGCGACT CATGGTGTCGTAGTGGATGC 157
OLIG2 GCTGCGTCTCAAGATCAACA CACCAGTCGCTTCATCTCCT 196
SDHAb TGGGAACAAGAGGGCATCTG CCACCACTGCATCAAATTCATG 84
aAll sequences are in a 5′–3′ direction.
bReference genes.
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(3% v/v) in PBS and 0.1% Triton x-100 (Sigma-Aldrich) overnight at
4 °C. Sections were washed and then incubated with fluorescently
conjugated secondary antibodies (Alexa Fluor® 594 donkey conjugated
anti-mouse, and Alexa Fluor® 488 donkey conjugated anti-rabbit
obtained from Molecular Probes®, Paisley, UK) for 2 h at room temp-
erature prior to washing and mounting in VectorShield (Vector labs).
Optical Densitometry
Quantification of density of Immunostaining for ASCL1, DLX2, GAD2,
and CALB2 was performed to confirm their tangential expression gra-
dients, using the ImageJ® 1.42 h software (NIH; http://rsbweb.nih.
gov/ij/ [date last accessed; 6 September 2013]). Photographs were
taken from the anterior- and posterior-most extents of sagittal sections
at 8, 9, 10, and 12 PCW for comparison (at least 2, usually 3, fetal
brains were examined at each age and 1 or 2 sections from each brain
were used for statistical analysis). All photographs were taken with the
same exposure time and cropped to similar widths. The average
optical density of histological staining in the CP and VZ was measured
in 3 rectangular boxes of equal widths for each section anteriorly and
posteriorly, which spanned the thickness of the CP, or the VZ, and
were placed adjacently. To take into account of background staining,
the ratio of mean gray values anterior to posterior in CP and VZ was
calculated.
Results
GABAergic Gene Expression in the Early Fetal Neocortex
A qPCR study was carried out to validate and extend the results
obtained from our previous microarray study (Ip et al. 2010).
In addition, we accessed publically available RNA seq data
(http://brainspan.org/rnaseq/search/index.html) at the rel-
evant developmental time points, and expressed all 3 datasets
in a way that makes them comparable (Fig. 1). All 3 approaches
gave broadly similar patterns of gene expression with nearly
all GABAergic genes selected for study showing higher
expression at the anterior compared with the posterior pole.
However, this only reached statistical significance for all
markers in the qPCR study. This validates the approach of col-
lecting global gene expression data by microarray or whole
RNA sequencing as a way of discovering potentially interesting
patterns of gene expression. Nevertheless, confirmation by
qPCR and other methods are still required.
The known posterior marker FGFR3 (O’Leary and Nakagawa
2002; Iwata and Hevner 2009) was more highly expressed at
the posterior pole in all 3 studies, showing that consistently
higher expression of the genes of interest at the anterior
pole was not some methodological anomaly. DLX5 showed the
consistently largest difference anterior to posterior. All transcrip-
tion factors showed broadly similar levels of expression,
although expression of ASCL1 was consistently high and was
the least regionalized, whereas OLIG2 usually showed the
lowest expression. Of the 2 glutamate decarboxylase isoforms,
GAD1 was generally more highly expressed than GAD2. CALB2
generally showed higher expression than the GAD genes
suggesting it may be expressed by cells other than GABAergic
interneurons. Of the GABA receptor subunit genes studied,
GABRB3 andGABRA5 exhibited some of the highest expression
levels of all transcripts studied, whereas GABRB1 showed low
expression.
Consistent patterns of expression over time were also ob-
served (Fig. 2). Nearly all genes showed increasing expression
with age. In most cases, anterior and posterior expression
levels increased in parallel, although anterior was consistently
higher than posterior. For some genes, notably DLX1, DLX5,
and GABRB3, expression at the anterior pole increased at a
faster rate than at the posterior pole. ISH studies confirmed the
expression of 4 of these genes, DLX1, 2, and 5 and GAD1, and
all showed gradients of expression from anterior to posterior
poles at 8 and 9 PCW (Fig. 3, DLX2 not shown). Although
expression of these genes was detected by ISH in the GE, as
would be expected from animal studies, expression was higher
in the neocortex, particularly at the anterior pole.
Demonstration of Gradients of Expression
by Immunohistochemistry
Whole sagittal sections of fetal brain were also successfully im-
munostained for 4 markers of GABAergic interneurons, DLX2,
ASCL1, GAD2, and CALB2 between 8 and 12 PCW weeks. At all
stages, a similar expression pattern was observed for DLX2,
ASCL1, and GAD2, with moderate expression in the GE, but
stronger expression in the CP (Fig. 4). There was also some
expression in the VZ/SVZ when compared with areas of comple-
tely negative staining in the diencephalon. CALB2 showed a
different pattern of staining. CALB2-positive neurons were
present in the postmitotic layers of the lateral (Fig. 5B,C) and
caudal (not shown) GE, but were absent from the MGE
(Fig. 4D). In the cortex, CALB2-positive neuronal cell bodies
were prominent in the cortical plate (CP) at 8–9 PCW, with fewer
also present in the marginal zone and subplate, but with many
Table 3
TISH probes
Probe Forward primer (SP6)* Reverse primer (T7)* Product size (bp)
DLX1 AATACGATTTAGGTGACACTATAGAATACGCACTACTCCATGCACTGTTTAC TAAGTTAATACGACTCACTATAGGGCGATGCTTCATCAGCTTCTTGAACTT 453
DLX2 AATACGATTTAGGTGACACTATAGAATACACAGCAGCTACTACACCAACCAG TAAGTTAATACGACTCACTATAGGGCGAACCACTTTTCCACATCTTCTTGA 455
DLX5 AATACGATTTAGGTGACACTATAGAATACTACGCTAGCTCCTACCACCAGTA TAAGTTAATACGACTCACTATAGGGCGACTTGTGTACCAGGATGCAGAGTT 497
GAD1 AATACGATTTAGGTGACACTATAGAATACGGATTGGATATTATTGGCCTAGC TAAGTTAATACGACTCACTATAGGGCGATCAAAAGCTCCATAAACAGTCGT 482
Table 4
Primary antibodies used in immunohistochemical studies
Primary antibody Manufacturer Catalog
no.
Species Dilution
used
Anti-MASH1/Achaete-scute
homolog 1 antibody
Abcam;
Cambridge, UK
ab74065 Rabbit
polyclonal
1:400
Anti-calretinin Swant; Marly,
Switzerland
6B3 Mouse
monoclonal
1:1000
Anti-calretinin Abcam;
Cambridge, UK
ab702 Rabbit
polyclonal
1:100
Anti-Dlx2 [4B9] Abcam;
Cambridge, UK
ab117546 Mouse
monoclonal
1:400
Anti-Dlx2: neural stem cell
marker
Abcam;
Cambridge, UK
ab18188 Rabbit
polyclonal
1:200
Anti-GAD65 [GAD-6]:
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Cambridge, UK
ab26113 Mouse
monoclonal
1:500
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Figure 1. qPCR confirmation of gradients of GABAergic gene expression between 8 and 12 PCW, and comparison with microarray and RNA seq data from previous studies. The
mean expression of the genes of interest, relative to the average expression of 3 reference genes, β-ACTIN, GAPDH, and SDHA, from RNA samples taken from the anterior and
posterior poles of the human neocortex between 8 and 12 PCW, is shown for qPCR data collected in the present study (A, n=8 fetuses) Affymetrix microarray (B, n=6, Ip et al.
2010) and RNA seq (C, n= 4, http://brainspan.org/rnaseq/search/index.html). The general patterns of expression are the same for all 3 studies, although the qPCR study shows less
experimental variability and thus detected differences between the anterior and posterior poles with greater confidence. Clear evidence is provided for higher anterior expression of
all GABAergic genes at this time. FGFR3 expression is included as an example of a posteriorly expressed gene. **P< 0.01, *P< 0.05, error bars represent 95% confidence limits.
Note that the chart is plotted on a logarithmic scale resulting in asymmetric error bars.
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immunoreactive fibers present in the subplate and intermediate
zone (Figs 4D and 5B). No immunostaining was present in the
proliferative zones at these earlier stages.
In many sections, a clear gradient of expression between the
anterior and posterior poles of the neocortex was discernible
at low magnification (Fig. 4). Optical density measurements of
immunostaining in the CP and ventricular zone (VZ) confirmed
a consistently higher density of staining in the anterior com-
pared with the posterior pole in nearly all sections studied, the
notable exception being DLX2 expression at 8 PCW (Fig. 4A).
The conclusion from these studies is that there was a higher
density of GABAergic neurons and their precursors in the
anterior pole of the neocortex but a more detailed study of
expression patterns was required to discern whether these
neurons are generated in the cortex, or migrate there from sub-
cortical structures at this stage of development.
Cellular and Laminar Localization of Expression
of GABAergic Markers in the Forebrain
At 6.5–7.5 PCW, we confirmed the presence of GAD2 and
CALB2 expressing neurons in the preplate as previously de-
scribed (Meyer et al. 2000; Rakic and Zecevic 2003). In addition,
DLX2 and ASCL1 immunoreactivity was observed. For all
markers, positive cells were seen in VZ, sometimes in radially
arranged clusters (Fig. 6). ASCL1 immunoreactivity was more
prevalent in the VZ, whereas the others showed stronger
expression in the preplate. This fits with the idea that ASCL1 is
expressed earlier in the development of interneurons (see Intro-
duction section) and strongly suggests that GABAergic cells are
born in the cortical wall at this stage of development. ASCL1,
DLX2, and GAD2 showed similar patterns of immunoreactivity
between 8 and 12 PCW, with a mosaic of cells exhibiting either
strong, moderate, and weak/no expression throughout the
layers of the cortical wall (Fig. 7). They differ in that ASCL1
expression is generally more prominent in the VZ, whereas
DLX2 was stronger in the SVZ. Despite being a marker for sy-
naptic terminals in adult tissue (Erlander et al. 1991; Esclapez
et al. 1994), GAD2 immunoreactivity was observed in prolifera-
tive layers (Fig. 6) as has been previously described (Petanjek
et al. 2009).GAD1 TISH staining was also most prominent in the
SVZ and CP at 9 PCW (Fig. 3C). In the CP, most GABAergic
markers showed more expression in cells closer to the outer
boundary with the marginal zone. The exception was CALB2,
immunoreactivity which was most prominent in cells at the in-
terface between the CP and the early SP. This confirms the pre-
vious suggestion (Meyer et al. 2000) that these CALB2 cells are
pioneer cells sending axons toward the thalamus rather than
GABAergic cells. CALB2-positive axons can be observed in the
Figure 2. Temporal changes in GABAergic gene expression by qPCR between 8 and 12 PCW. The expression of the genes of interest, relative to the average expression of 3
reference genes, from RNA samples taken from the anterior and posterior poles of the human neocortex between 8 and 12 PCW, is shown for qPCR data collected in the present
study (n= 8 fetuses). Statistically significant linear correlations of expression over time (P< 0.05) are marked with a line. It can be seen that nearly all genes showed increased
expression, both anteriorly and posteriorly, with age, although for some genes, notably DLX5 and GABRB3, expression increased more quickly anteriorly, compared with posteriorly.
FGFR3 expression is included as an example of a posteriorly expressed gene.
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early SP, intermediate zone, and into the internal capsule and
CALB2 positive GABAergic neurons may exist at other locations
in the CP and early SP.
By 12 PCW, as previously described (Bayatti, Moss et al.
2008), CALB2-positive neurons were now observed in the pro-
liferative zones and intermediate zone, particularly at the
anterior pole (Fig. 8). Many of these cells were of bipolar ap-
pearance, suggesting they are migratory cells. There was a
mixture of radially and tangentially orientated cells, and align-
ments in between (Fig. 8B). At this stage, other GABAergic
genes were also expressed, including GAD1 and DLX2 de-
tected by ISH (Fig. 8A) and also DLX2 by IHC. In each case,
expression was prominent in the upper CP and outer SVZ
(OSVZ). DLX2 immunoreactivity was also prominent in the
inner SVZ (ISVZ) but not the VZ, whereas DLX2 mRNA
expression was observed in the VZ (Fig. 8A). In order to
confirm the expression of GABAergic markers in proliferating
cells in the cortical wall, double immunofluorescent staining
was carried out for the cell division marker Ki67 (Brown and
Gatter 1990; Zecevic et al. 2011) and either ASCL1, DLX2, or
CALB2 (Fig. 9). All 4 proteins were detected in the VZ and SVZ
at 11 PCW, although DLX2 positive cells were mostly confined
to the ISVZ. Only ASCL1 and DLX2 showed extensive double-
labeling with Ki67; no CALB2 positive cells were found to be
also Ki67 positive.
These observations point toward intracortical generation of
GABAergic neurons but to what extent might subcortical inter-
neurons invade the cortical wall at this stage of development?
Expression of GABAergic markers was clearly seen in the GE.
At stages up to 7.5 PCW, before formation of the CP, a promi-
nent migratory stream of cells expressing some GABAergic
markers such as GAD2 and CALB2 was seen extending from
the GE toward the early subplate (Fig. 6F,G). However, even at
these stages, GABAergic genes (e.g., GAD2 and OLIG2)
showed expression in the CP that was stronger in dorsal and
anterior regions of dorsal pallium than in the ventral pallium at
the border with the GE (Fig. 6D,E). From 8 PCW onward,
expression of GABAergic genes was not as strong in the GE as
in the cortical wall. CALB2 immunoreactive cells were only
present in lateral ganglionic eminence (LGE) and CGE, and not
in the MGE (Fig. 4D) and only a very few CALB2-positive
neurons appeared to be migrating from the GE into the early
SP and intermediate zone of the dorsal pallium (Fig. 5C). For
all markers, a continuous band of positive staining between
the postmitotic zones of the GE and the strong labeling of the
anterior cortical wall was not observed; rather, there was a
break, or reduction, in expression at the boundary between
the pallium and the subpallium (Figs 3 and 4). This was par-
ticularly apparent in the pattern of expression shown by DLX5
in Figure 5A.
Discussion
It is known that GABAergic neurons are present in the pre-
plate, and there is strong evidence that at least some of these
are generated intracortically (Zecevic et al. 1999; Meyer et al.
Figure 3. Expression gradients for GABAergic genes shown by in situ hybridization. Examples of DLX expression are shown in lateral sagittal sections at 8 PCW (A,B). There was
moderate expression in the lateral ganglionic eminence (LGE) but weakest expression at the boundaries between ventral pallium (VP) and LGE before moderate expression resumes
in the VZ and SVZ, and strong expression was observed in the cortical plate (CP) of the VP and dorsal pallium (DP). A gradient of expression from anterior (Ant) to posterior (Pos)
poles of the cortex was also discernible. GAD1 expression was shown at 9 PCW in a medial section (C). In subcortical structures, expression was relatively strong in the lateral and
medial (MGE) ganglionic eminences, and in the thalamus (Th) but weak in the prethalamus (PrTh). There was less expression at the boundary of the LGE with the cortex (ventral
pallium, VP) but relatively high expression in the anterior cortical wall compared with the posterior. Higher magnification images show GAD1 expression throughout the anterior
cortical wall but highest in the SVZ and CP where many, but not all, cells appear stained. In the early subplate and intermediate zone (SP/IZ), an area of low cellular density, heavily
stained cells are discernible, while in the VZ only a few moderately stained cells can be seen. In the posterior cortical wall, the pattern was similar although staining was less
intense. Scale bar represents 100 μm in high-magnification images and 800 μm at low magnification. The orientation of all the section images are the same, hence Ant and Pos are
the same as indicated in A.
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2000) supported by observations made in the present study.
There is also good evidence that, around midgestation in
humans, the cortical proliferative zones generate CALB2 posi-
tive interneurons in particular, which populate the outer layers
of the cortex (Jakovcevski et al. 2011). However, what occurs
during the developmentally important period between for-
mation of the CP and innervation of the subplate by thalamic
afferents (8–15 PCW) has not been studied in so much depth.
In vitro experiments with cultured fetal tissue fragments
(14/15 PCW) failed to find any evidence of generation of
GABAergic neurons by cortical proliferative cells (Hansen
et al. 2010) challenging the conclusion drawn from the first
studies to explore this question (Letinic et al. 2002; Rakic and
Zecevic. 2003) that interneurons were intracortically generated
at this stage. A more recent study has found cells positive for the
GABA neuron indicative transcription factors DLXs, NKx2.1,
Figure 4. Expression gradients for immunoreactivity to GABAergic markers confirmed by optical densitometry. IHC for four proteins was selected for measurement at multiple
ages; DLX2 (A), ASCL1 (B), GAD2 (C), and CALB2 (D). Low power images of immunostaining for each protein are shown, all at 9 PCW in medial sagittal sections. DLX2, ASCL1, and
GAD2 all show moderate immunoreactivity in the medial ganglionic eminence but stronger expression in the neocortex, especially in the cortical plate (CP) but also in the ventricular
and subventricular zone (VZ/SVZ) and a gradient of expression from the anterior to posterior pole of the neocortex. CALB2 also shows a gradient of expression, but differs from the
other 3 in showing moderate expression in fibers in the subplate and intermediate zone (SP/IZ) but low expression in VZ/SVZ and the MGE. The ratio of anterior to posterior labeling
density was calculated for each section and the mean plotted. Error bars represent 95% confidence limits of the mean, which are sometimes close enough together to be obscured
by the representative symbol. With the exception of DLX2 expression at 8 PCW, there was consistently higher expression anteriorly for all genes and time point studied. The
prethalamus (PrTh) and thalamus (Th) show low immunoreactivity for all four markers, with the exception of CALB2 expression in the thalamus. Scale bar = 2 mm. The orientation
of all the section images is the same, hence Ant and Pos are the same as indicated in A.
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and LHX6 in the VZ and CP between 8 and 15 PCW (Jakovcevski
et al. 2011) but in a limited number of samples (3) and the
authors suggest that these may have migrated into the cortical
wall from the GE. A study in macaque has suggested that
GABAergic cells populating the early CP migrate there from
the GE prior to a later wave of intracortical interneuron gener-
ation (Petanjek et al. 2009). It is conceivable that cells originat-
ing from the GE retain the ability to proliferate on reaching the
cortical SVZ (Lui et al. 2011). We have now made an extensive
study of GABAergic gene expression in the neocortex between
8 and 12 PCW and found robust evidence for expression of a
wide range of genes associated with GABAergic neurogenesis
and neurotransmission during the earliest stages of CP for-
mation, confirming that the cortical cerebral wall is populated
with GABAergic neurons and their precursors at this stage. But
In addition, we have shown that there is a higher expression of
these genes at the anterior pole of neocortex compared with
the posterior pole, by qPCR, ISH, and IHC.
Our qPCR analysis showed that the expression of these
genes, relative to reference genes, was generally found to in-
crease between 8 and 12 PCW, suggesting that the GABAergic
neurons are being added to in number, and undergoing differ-
entiation, throughout this period. Although previous studies
have shown that GABA synthesis is present at the earliest
stages of neuronal specification (Del Rio et al. 1992; Zecevic
and Milosevic. 1997) transcription factors involved in inter-
neuron specification (ASCL1, the DLXs, LHX6, OLIG2) appear
to be more highly expressed than the key markers of differen-
tiation; GAD1 and GAD2. This would indicate that many
GABAergic neurons are new born and/or have not undergone
extensive differentiation and this is supported by our histologi-
cal observations that show that many of these genes and their
proteins are expressed in the proliferative zones or in small,
undifferentiated cells in the CP. Only a relatively small number
of GABAergic cells in the subplate and marginal zone have ex-
tended dendrites and axonal arbors at this stage and are likely
to be integrated into active neural circuitry (Moore et al. 2009;
Wang, Hoerder-Suabedissen et al. 2010) whereas the tightly
packed cells of the CP are very largely electrically inactive up
to ages beyond those examined in this study (Moore et al.
2009). Furthermore, ASCL1, the earliest marker for interneuron
specification (Yun et al. 2002) was the most highly expressed
transcription factor studied, it was found at a higher level in
the VZ than the others (Figs 6 and 7) and was extensively co-
expressed with a cell proliferation marker (Fig. 9). This
strongly suggests an intracortical origin for a high proportion
of these GABAergic cells. However, it should be borne in mind
that co-expression of Ascl1 and Olig2 in rodents can also
specify an early population of oligodendrocyte precursors in
the forebrain (Parras et al. 2007) although the oligodendrocyte
precursor-specific marker PDGFR-α receptor is only expressed
by a tiny proportion of cells in the human forebrain before 15
PCW at which time numbers begin to increase (Jakovcevski
et al. 2009).
Other postdifferentiation markers, CALB2, and the GABRA5
and GABRB3 receptor subunits, were also more highly ex-
pressed than the GADs. This may be because these markers are
not confined to GABAergic neurons. It is known that CALB2 is
expressed by Cajal–Retzius cells in the marginal zone (Verney
and Derer 1995; Meyer et al. 2000) and by pioneer neurons of
the lower CP that extend axons toward the thalamus (Meyer
et al. 1998, 2000). We have no evidence for expression of
protein products of GABA-A receptor subunit genes and so the
mRNA expression may be misleading, however, expressions
levels could be higher because receptors can be expected to be
localized to any cell that is a target for GABAergic neurotrans-
mission, or even autocrine/paracrine transmission. It is well es-
tablished in model systems that GABA is released tonically
from immature cells that have yet to develop a vesicular mode
of transmitter release (Demarque et al. 2002). There is evi-
dence that signaling through GABA-A receptors might control
proliferation in progenitor cells (Lo Turco et al. 1995; Haydar
et al. 2000; Wang and Kriegstein 2009). Migrating neurons, of
all phenotypes, in the cortex express GABA-A receptors, stimu-
lation of which promotes migration away from the proliferative
zones but stops migration in the appropriate cortical layer
(Behar et al. 2000; Manent and Represa 2007). Gabra5 has re-
cently been identified as a SP marker in rodent where it is also
expressed in an anterior to posterior gradient (Oeschger et al.
2012). GABRB3, which showed remarkably high expression, is
Figure 5. Expression of GABAergic genes in horizontal sections at 8 PCW. Staining
patterns for ISH for DLX5 (A), and IHC for CALB2 (B) in horizontal sections at 8 PCWs
serve to further illustrate that there were 2 centers of strongest expression, in the
ganglionic eminence, and in the dorsal pallium, particularly at more anterior (Ant)
locations, with no evidence of a gradient of expression between the sub pallium and
dorsal pallium that would suggest a migratory stream of cells moving between the 2.
Indeed, there appeared to be distinct break in DLX5 expression between the
postmitotic layers of the ganglionic eminence (GE) and cortical plate of the ventral
pallium (arrow). However, at higher magnification, a few CALB2-positive neurons
appeared to be crossing this zone (C, small arrows). Scale bar = 100 μm in A,B;
300 μm in C. The orientation of all the section images are the same, hence Ant is the
same in B indicated in A (C is image of section in B at higher magnification).
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implicated in autism-related disorders and neurodevelopmen-
tal epilepsy (Buxbaum et al. 2002; Kang and Barnes 2013).
GABRB1 showed relatively low expression, as is the case in the
mature CNS (Olsen and Sieghart 2008). Further study of the
cellular localization of these subunits in developing human
brain is required and might provide important clues as to the
function of GABA in cortical development and their impli-
cation in neurodevelopmental diseases.
Why is There Higher Expression in the Anterior
Neocortex?
Three possible mechanisms, alone or a combination, may
explain higher GABAergic gene expression at the anterior cor-
tical pole. First, the anterior cortex may mature more quickly
than the posterior pole and express higher levels of markers of
neuronal differentiation earlier. Second, there is extensive
migration of GABAergic neurons and/or their precursors from
Figure 6. Expression of GABAergic genes prior to cortical plate formation. Immunoreactivity for ASCL1 (A) GAD2 (B) and DLX2 (C) a little later was detectable both in cells of the
proliferative ventricular zone (VZ) and postmitotic preplate (PP) confirming GABAergic neurons are born in the cortex at this early stage. Arrows point to radially orientated
aggregates of cells expressing GAD2 and DLX2 suggesting these cells were being born in the ventricular zone and migrating radially. Low power images confirm that both OLIG2 (D,
coronal section) and GAD2 (E, sagittal section) were as strongly expressed in the anterior/dorsal regions of the dorsal pallium as in the ganglionic eminences at this stage, although
at higher magnification in coronal sections, it was possible to see a prominent tangential stream of cells (curved arrow) either expressing GAD2 (F) or CALB2 (G) apparently
migrating from the ganglionic eminence toward the preplate. Scale bars = 50 μm in A, B, C; 500 μm in F, G; and 2 mm in D, E.
Figure 7. Laminar expression of GABAergic immunoreactivity at 9 PCW. ASCL1, DLX2, and GAD2 show similar patterns of immunoreactivity at 9 PCW, with a mosaic of cells
exhibiting either strong, moderate, and weak/no expression throughout the layers of the cortical wall. They differed in that ASCL1 expression was generally more prominent in the
VZ, whereas DLX2 was stronger in the SVZ. GAD2 immunoreactivity was observed in proliferative layers as well as in postmitotic cells. In the cortical plate (CP), most GABAergic
markers showed more expression in cells closer to the outer boundary with the marginal zone. The exception was CALB2 immunoreactivity, which was most prominent in cells at
the interface between the CP and the early subplate (SP/IZ). CALB2-positive fibrers were also seen extending into the intermediate zone (IZ), but no CALB2-positive cells were seen
in the SVZ/VZ at this stage. Scale bar = 200 μm.
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the LGE/MGE into the anterior cortical wall at this stage of de-
velopment. Third, the anterior neocortex is a preferred site for
interneuron generation at this time.
Cortical development appears to unfold along an anterior/
lateral to posterior/medial axis, judging by the thickness of the
CP, which develops first in the lateral cerebral wall close to the
future corticostriatal junction (Müller and O’Rahilly 1990;
Zecevic 1993). But this is a simplification, as posterior parts of
the frontal cortex develop before the anterior regions, with the
prefrontal cortex taking the longest to develop in primates
(Fuster 2001; Burman et al. 2007). Our previous microarray
analysis of human areal gene expression found twice as many
gene probe sets to be relatively highly expressed anteriorly
than those highly expressed posteriorly, but nevertheless the
vast majority of genes showed no marked differences, includ-
ing pan-neuronal markers such as synaptophysin, MAP2 and
β-tubulin, and transcription factors important in development
such as PAX6, FEZF2, and SOX5, which was confirmed by
qPCR, ISH, and/or IHC (Ip et al. 2010; Ip et al. 2011). There-
fore, there is no clear evidence for anterior regions maturing
more quickly in terms of gene expression and differentiation.
Nevertheless, there is differential gene expression across the
early human neocortex (Ip et al. 2010) including arealization
genes such as EMX2, COUP-TFII, and FGFR3, identified in
rodent studies as important in establishing the protomap
(O’Leary and Nakagawa 2002; Rakic 2009) and areally ex-
pressed genes that define the protomap, such as cell adhesion
molecules that control cell migration and axon pathway
finding (e.g., CNTNAP2, PCDH17, ROBO1) are more highly ex-
pressed anteriorly (Abrahams et al. 2008; Ip et al. 2010; Ip
et al. 2011).
In addition to qPCR evidence, histological preparations
showed that although there is evidence of migration from the
GE to the cortex at earlier stages (7.5 PCW, Fig. 6F,G), we see
no similar streams of cells at later stages (8–12 PCW). Further-
more, expression of ASCL1 to be high and prominent in the
VZ, and high in the CP, which can be interpreted as evidence
for intracortical generation of GABAergic interneurons, as
ASCL1 expression is downregulated in migratory ganglionic
eminence-derived interneurons before they enter the dorsal
pallium (Letinic et al. 2002). Crucially, we co-localized ASCL1
expression to cells undergoing proliferation (Fig. 9). The
Figure 8. Laminar expression of GABAergic genes at 12 PCW. Panel (A) shows at low magnification the expression of GAD1 and DLX2 by ISH, and DLX2 and CALB2 by IHC. GAD1
expression indicated the presence of GABAergic neurons in the cortical plate at this stage, and the expression of DLX2/DLX2 in the proliferative zones suggests that GABAergic cells
may have been generated intracortically at this stage. This stage of development is noticeable for the appearance of CALB2 immunoreactive neurons in the VZ, SVZ, and
intermediate zones. At higher magnification (B), many of these CALB2-positive cells appeared migratory, but have a mix of orientations suggestive of tangential or radial migration.
Note that the marginal zone (MZ) has a cell-containing outer layer (subpial granular layer) at this age. Scale bar = 500 μm in A; 100 μm in B.
Figure 9. Double labeling of GABAergic interneuron precursors with the cell-division marker Ki67. Ki67 immunofluorescence (red) was observed in many cell nuclei throughout the
proliferative layers of the neocortex. This coincided with expression of the transcription factors ASCL1 and DLX2 (green) and a majority of cells appeared double labeled for Ki67 and
either one of the transcription factors (yellow, 9A,B). DLX2 was less widely expressed than ASCL1, being largely confined to the ISVZ (B). CALB2 was also widely expressed in the
SVZ (green, C) but was not seen to be co-expressed with Ki67. Scale bar = 100 μm.
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expression of a number of other markers, including DLXs,
CALB2, and GAD2 was also higher in the cortical wall than in
the GE, a reverse of the gradient expected if inhibitory inter-
neurons were predominantly migrating from subcortical to cor-
tical structures. These markers were also strongly expressed in
the SVZ, and we found dividing cells that were positive for
DLX2. In a previous study, in organotypic cultures of forebrain
at 10 PCW, 95% of newborn cells exhibit radial migration
within the dorsal pallium and hardly any cells migrated tangen-
tially across the subpallial/pallial border and never into the VZ
(Letinic et al. 2002). Many GABAergic transcription factors
(DLXs, NKx2.1, and LHX6) as well as GABA are detectable in
cells of the VZ and SVZ, as well as outer layers, at this stage of
development (Letinic et al. 2002; Rakic and Zecevic 2003;
Jakovcevski et al. 2011) and the present study. Therefore, we
propose that the anterior cortex is a genetically determined
center for preferential generation of cortical interneurons. Differ-
ences in the capacity to generate GABAergic neurons from orga-
notypic cultures of cortex (Letinic et al. 2002; Hansen et al. 2010)
may depend on the anterior or posterior origin of the tissue.
We observed that the ventral pallium showed weaker ex-
pression of GABAergic markers compared with either the
lateral/caudal GE or the dorsal pallium. A cloned neurogenic
progenitor cell line produced from embryonic rat cortex gener-
ates interneurons in response to the ventral signaling molecule
sonic hedgehog (Shh) however, this is suppressed by the dorsal
signaling molecule Bmp2 (Li et al. 2008). Possibly, all mamma-
lian cortex possesses the capacity to generate GABAergic inter-
neurons when stimulated with ventralizing factors, as this can
be achieved in vitro with rodent cortical tissue even if there is
scant evidence of this occurring in vivo (Welagen and Anderson
2011). In human, our preliminary observations suggest that
the ventral pallium may produce “dorsal” signaling molecules,
as its pattern of gene expression resembles dorsal cortical
hem (Sarma et al. 2013) which could locally inhibit interneuron
generation. However, more dorsal and anterior regions come
under the influence of the anterior neural ridge, which releases
“ventral” signals (Monuki 2007). Holoprosencephaly is caused
by disruption of genes contributing to the SHH-signaling
pathway active in specifying rostroventral structures in the
subpallium and results in selective loss of GABAergic cells
characteristic of MGE derived interneurons in the neocortex
(Fertuzinhos et al. 2009). If, in human, rostroventral gene
expression domains also appear in the dorsal pallium then intra-
cortical generation of GABAergic interneurons would also be
disrupted by holoprosencephaly. It is known that genes impli-
cated in this condition, for example, FGFR1 and FGFR2
(Fernandes and Hébert 2008) are expressed in the human fetal
neocortex (Ip et al. 2010).
Primates display a complexity in layer I of the cortex not
found in rodents (Meyer et al. 1998; Zecevic and Rakic 2001).
In humans, around 11 PCW, the subpial granular layer (SGL)
starts forming from cells observed to spread from the olfactory
region to the nearby anterior/ventral cortex, and can be seen
in sections in the present study at PCW12 (Fig. 8). By 13 PCW,
the SGL covered the entire cortical surface of the forebrain, the
SGL consists of small GABAergic cells and large Reelin-positive
Cajal–Retzius cells; the GABAergic cells being able to undergo
inward migration into the CP (Zecevic and Rakic 2001; Rakic
and Zecevic 2003). During the time period studied in this
experiment, the SGL could potentially provide a component of
raised anterior GABAergic gene expression.
Also, from 10 PCW, increasing numbers of CALB2-positive
neurons were observed in the IZ, SVZ, and VZ. Many show
morphology distinctive of tangentially migrating neurons and
may represent neurons migrating into the neocortex from
ventral locations. In organotypic slice culture experiments, tan-
gentially migrating cells were only observed in the SVZ/VZ in
large numbers for the first time at 14 PCW, however, 70% of
these expressed both DLX1/2 and ASCL1, and are thus likely to
have been generated intracortically (Letinic et al. 2002). We
propose that interneurons are generated intracortically predomi-
nantly in the frontal lobe and may migrate away from this site to
populate other cortical areas. The cerebral cortex has expanded
at a much faster rate than ventral telencephalic structures in the
course of evolution of primates compared with rodents, and so it
is logical that extra sources of interneurons might be required to
populate the primate cortex. Furthermore, the frontal lobe in par-
ticular may show greater expansion in primates (Rakic 2009).
A proportion of human GABAergic forebrain neurons express
the transcription factor COUP-TFII (Reinchisi et al. 2012). In the
rodent, this transcription factor identifies interneurons of CGE
origin and controls their migration via a caudal stream into the
posterior cortex (Yozu et al. 2005; Kanatani et al. 2008; Miyoshi
et al. 2010) and, in human, this gene is also predominantly ex-
pressed by interneuron precursors of the CGE compared with
the MGE (Reinchisi et al. 2012). In the cerebral cortex, at mid-
gestation, around a quarter of all GABAergic cells and three quar-
ters of all CALB2-positive cells in the CP co-express COUP-TFII
and a small proportion of dividing cells in the SVZ/VZ also
express COUP-TFII. Intriguingly, there is a posterior/lateral to
anterior gradient of COUP-TFII expressing cells at 15–22 PCW in
the cerebral cortex, interpreted as caudal stream of migration of a
population of interneurons generated in the CGE and probably
the posterior and temporal cortical proliferative layers (Reinchisi
et al. 2012). There also may be a lateral/posterior to anterior gra-
dient of COUP-TFII expression at 8–12 PCW (http://brainspan.
org/rnaseq/search/index.html) although at this stage, cells ex-
pressing the transcription factor seem to be largely confined to
the presubplate and SP (Reinchisi et al. 2012) or the CGE. There-
fore, the pronounced anterior to posterior gradient of CALB2
expression we observe at this time, which is augmented by the
appearance of postmitotic CALB2 immunoreactive cells in the
proliferative zones from 10 PCW, appears to derive from a differ-
ent population than the COUP-TFII-expressing interneurons that
appear at later stages.
Conclusion
Our study provides substantial evidence for the capacity of
human cortical progenitor cells to generate inhibitory inter-
neurons. In addition to prior findings that this occurs before
the formation of the CP, and also from midgestation, we now
show that it may occur at the earliest stages of CP formation
and to a greater extent towards the anterior pole of the cortex.
This should provide interneurons to populate the lower layers
of the CP which are forming at this time (Ip et al. 2011) which,
in rodents, are predominantly derived from the MGE and
characterized by expression of DLX transcription factors (Butt
et al. 2005). At this stage, in human, expression of the DLXs ac-
tually appeared higher in the cortex than in the MGE by ISH
(Fig. 3) and, in agreement with Letinic et al. (2002), we
propose that tangential migration from the MGE to cortex
starts at a later stage.
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